Skip to content

Clinical trials

Phase 3 Influenza, Human trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Phase: Phase 3 Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20092
20111
20141
20192
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Active, not recruiting1
Suspended1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Chinese University of Hong Kong3
The University of Hong Kong2
AstraZeneca1
Hoffmann-La Roche1
MedImmune LLC1
Nanogen, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human13
Respiratory Tract Infections2
COVID-191
Coronavirus Infections1
Infections1
Lung Diseases1
Lymphoma, Follicular1
Orthomyxoviridae Infections1
Respiratory Distress Syndrome1
Respiratory Tract Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.